Skip to main content

Published locations for Methotrexate-associated hepatotoxicity risk differs between psoriasis, PsA, and RA patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Methotrexate-associated hepatotoxicity risk differs between psoriasis, PsA, and RA patients

User login

  • Reset your password
  • /content/methotrexate-associated-hepatotoxicity-risk-differs-between-psoriasis-psa-and-ra-patients
  • /edermatologynews/article/236417/psoriasis/methotrexate-associated-hepatotoxicity-risk-differs
  • /familypracticenews/article/236417/psoriasis/methotrexate-associated-hepatotoxicity-risk-differs
  • /gihepnews/article/236417/psoriasis/methotrexate-associated-hepatotoxicity-risk-differs-between
  • /internalmedicinenews/article/236417/psoriasis/methotrexate-associated-hepatotoxicity-risk-differs
  • /rheumatologynews/article/236417/psoriasis/methotrexate-associated-hepatotoxicity-risk-differs
  • /rheumatology/article/236417/psoriasis/methotrexate-associated-hepatotoxicity-risk-differs-between
  • /internalmedicine/article/236417/psoriasis/methotrexate-associated-hepatotoxicity-risk-differs
  • /dermatology/article/236417/psoriasis/methotrexate-associated-hepatotoxicity-risk-differs-between
  • /familymedicine/article/236417/psoriasis/methotrexate-associated-hepatotoxicity-risk-differs-between
  • /psoriatic-arthritis-icymi/article/236417/psoriasis/methotrexate-associated-hepatotoxicity-risk